Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of Lycojaponicumin C in preparation of medicine for treating hemorrhagic fever with renal syndrome

A technology for renal syndrome and hemorrhagic fever, applied in the direction of drug combinations, medical preparations containing active ingredients, pharmaceutical formulas, etc., can solve problems such as uncertain effects, and achieve strong inhibitory activity of hemorrhagic fever with renal syndrome virus and highlight the essence The effect of sexuality

Active Publication Date: 2013-12-25
山西明鼎医药科技有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Antiviral treatments such as ribavirin and interferon are often used clinically, but the effect is not yet certain

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of Lycojaponicumin C in preparation of medicine for treating hemorrhagic fever with renal syndrome
  • Application of Lycojaponicumin C in preparation of medicine for treating hemorrhagic fever with renal syndrome
  • Application of Lycojaponicumin C in preparation of medicine for treating hemorrhagic fever with renal syndrome

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0012] Embodiment 1: the preparation of the compound Lycojaponicumin C tablet involved in the present invention:

[0013] Take 20 grams of compound Lycojaponicumin C, add 180 grams of conventional excipients for tablet preparation, mix well, and make 1000 tablets with a conventional tablet press.

Embodiment 2

[0014] Embodiment 2: the preparation of the compound Lycojaponicumin C capsules involved in the present invention:

[0015] Get 20 grams of compound Lycojaponicumin C, add conventional auxiliary materials for preparing capsules such as 180 grams of starch, mix well, and pack into capsules to make 1000 tablets.

[0016] The following pharmacodynamic experiments will further illustrate its drug activity.

[0017] In order to better understand the essence of the present invention, the following experimental research results of Lycojaponicumin C will illustrate its application in the pharmaceutical field.

[0018] The specific experiment is as follows:

[0019] 1. Experimental study of Lycojaponicumin C against hemorrhagic fever with renal syndrome virus

[0020] (1) In vitro inhibition experiment of hemorrhagic fever with renal syndrome virus

[0021] 1 material

[0022] (1) Virus strain: the international standard strain of hemorrhagic fever with renal syndrome virus 76-118,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a new application of Lycojaponicumin C in preparation of a medicine for treating hemorrhagic fever with renal syndrome. Experimental researches of Lycojaponicumin C in-vitro and in-vivo inhibition on virus of hemorrhagic fever with renal syndrome indicate that Lycojaponicumin C has low toxicity to cells, can directly kill virus of hemorrhagic fever with renal syndrome, can remarkably inhibit multiplication of the virus, and can obviously protect shrewmouse infected by the virus so as to delay the disease time, prolong the course of disease and reduce the death rate. Therefore, the Lycojaponicumin C is an effective and safe medicine for treating hemorrhagic fever with renal syndrome.

Description

technical field [0001] The present invention relates to the use of Lycojaponicumin C, in particular to the use of Lycojaponicumin C in the pharmaceutical field. Background technique [0002] There are 13 kinds of human viral hemorrhagic fever in the world. According to whether the disease has kidney damage, it is divided into two categories: with kidney damage and without kidney damage. In my country, it is mainly hemorrhagic fever with renal syndrome (HFRS), also known as epidemic hemorrhagic fever. Hemorrhagic fever (EHF); called Korean hemorrhagic fever (KHF) in North Korea; called hemorrhagic nephritis nephritis (HNN) in the Soviet Union; due to the establishment of specific serological diagnosis and the resolution of etiology, in 1982, the World Health Organization named it as renal syndrome Symptoms of hemorrhagic fever. [0003] The disease is caused by Korean hemorrhagic fever virus (or Hantaan virus), a natural foci disease with rodents as the main source of infectio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/438A61P13/12A61P31/14
Inventor 吴俊华刘洋
Owner 山西明鼎医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com